Project Grant R21AI190343
Award Date 9/17/25
Completion Date 8/31/27
Dollars Obligated $448K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded Georgetown University a $429,000 Project Grant to conduct research on "Cell-Type-Specific Evaluation of Liver Allografts During Normothermic-Machine-Perfusion." The grant, awarded under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to advance the use of normothermic machine perfusion (NMP) technology and cell-free methylated DNA (cfDNA) monitoring to assess the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,000,000 Project Grant to Partillion Bioscience Corp, a biotechnology company based in Los Angeles, California. The grant, funded under NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of advanced workflows utilizing Partillion's specialized hydrogel microparticle technology called "nanovials". The goal is to enable ultra high-throughput screening and functional...
- The University of California, San Diego (UCSD) was awarded a $3,194,992.00 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, awarded on July 16, 2025, supports research to study the roles and regulation of tissue-resident CD8 T cells during a persistent viral infection. The research aims to investigate the mechanisms that allow immune cells to adapt and maintain a long-term...
- The University of South Florida (USF) received a $480,522 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant supports research to investigate the regulation and role of the secreted proteases of the bacterium Staphylococcus aureus, a major cause of infectious disease. The research aims to elucidate how these enzymes mediate S. aureus pathogenesis and virulence, with...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $4,259,368 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis, Missouri. The award, effective from July 25, 2025 through June 30, 2029, will fund research to elucidate the novel functions of the ion channel TRPV2 in regulating the cGAS/STING-mediated innate immune response. The project...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $879,906 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Cedars-Sinai Medical Center in California. The grant, awarded on June 20, 2025, supports research to explore the role and cellular sources of the pro-inflammatory mediator HMGB1 in an experimental murine model of Kawasaki disease vasculitis. The research aims to better understand the pathogenesis of Kawasaki disease, a...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $171,254 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Nimml Institute Inc., a 501(c)(3) non-profit research organization in Blacksburg, Virginia. The grant, effective from December 1, 2024 to November 30, 2026, aims to elucidate novel immunometabolic mechanisms that intercept bacterial toxin internalization and processing to suppress cell damage caused by Clostridioides difficile...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $779,235 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to the University of California, Santa Cruz to study the mechanisms and consequences of cyclic di-GMP control of motility and biofilm formation in Vibrio cholerae. The research aims to address major gaps in understanding the interplay between V. cholerae's flagellum, pili, and cyclic di-GMP signaling in the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,832,747 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Irvine (UCI) to study the role of SAPS3 in regulating T cell immunity during chronic infections. The research aims to investigate how SAPS3, a negative regulator of AMPK, impacts the function and exhaustion of virus-specific CD8+ and CD4+ T cells. Preliminary data indicates that SAPS3...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $368,750 Project Grant to the Veterans Medical Research Foundation of San Diego through the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The project aims to determine the mechanisms by which the short isoform of the BST2 protein, which has broad antiviral activity, is antagonized by HIV-1 and HIV-2. This research seeks to understand how HIV evades this key cellular defense and the...